文献速递消化内镜消化道肿瘤与早癌

首届全球消化病学与内镜人工智能峰会会议纪要

Proceedings from the First Global Artificial Intelligence in Gastroenterology and Endoscopy Summit.
PubMed 文献 · Gastrointest Endosc · 2020-04-25

本文报告2019年9月28日多学科专家会议成果,汇集消化病学、计算机与影像科学、机器学习、FDA及NIH专家,评估AI在消化内镜中的应用现状并提出研究建议。专家共识认为AI将变革消化病学尤其内镜与图像判读,需建立内镜图像库EndoNet并明确监管与试验终点。

要点

  • AI尤其深度学习有望提升内镜病变检测、分类、质量指标与记录。
  • 专家共识认为AI将变革消化病学,重点在内镜与图像判读。
  • 大型内镜图像库EndoNet对AI系统开发与应用很重要。

核心结论

  • 消化病学是AI早期应用的理想领域,AI正从实验阶段迈向临床实施阶段。
  • 未来十年AI实施预计对患者诊疗和临床工作流程产生显著积极影响。

研究设计与样本

  • 2019年9月28日召开多学科会议,汇集消化病学、计算机与影像科学、机器学习、计算机视觉、FDA及NIH专家。
  • 会议展示并讨论消化病学近期与正在进行的研究及当前AI技术,识别关键知识空白并提出高影响力研究建议。

主要发现

  • 专家共识认为AI将变革消化病学,尤其内镜与图像判读。
  • 先进机器学习算法驱动的计算机视觉在内镜中有望改善消化病与癌症患者的预测和治疗结局。
  • 大型内镜图像库EndoNet对促进AI系统开发与应用很重要。

关键数值与推荐

  • AI系统实施的监管环境仍在演变,结肠息肉检测等共同结局被列为潜在临床试验终点。
  • 其他阈值结局以及临床系统迭代改进的清晰度也很重要。

临床怎么用

  • 消化内科医生应关注AI在内镜病变检测、分类、质量指标与记录中的应用。
  • 临床实施需兼顾监管要求、试验终点选择及临床系统迭代改进的清晰度。

局限性

  • 需进一步探索潜在临床应用、实施、结构与治理、消化内科医生角色及AI潜在影响等约束与领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Artificial intelligence (AI), specifically deep learning, offers the potential to enhance the field of GI endoscopy in areas ranging from lesion detection and classification to quality metrics and documentation. Progress in this field will be measured by whether AI implementation can lead to improved patient outcomes and more efficient clinical workflow for GI endoscopists. The aims of this article are to report the findings of a multidisciplinary group of experts focusing on issues in AI research and applications related to gastroenterology and endoscopy, to review the current status of the field, and to produce recommendations for investigators developing and studying new AI technologies for gastroenterology. METHODS: A multidisciplinary meeting was held on September 28, 2019, bringing together academic, industry, and regulatory experts in diverse fields including gastroenterology, computer and imaging sciences, machine learning, computer vision, U.S. Food and Drug Administration, and the National Institutes of Health. Recent and ongoing studies in gastroenterology and current technology in AI were presented and discussed, key gaps in knowledge were identified, and recommendations were made for research that would have the highest impact in making advances and implementation in the field of AI to gastroenterology. RESULTS: There was a consensus that AI will transform the field of gastroenterology, particularly endoscopy and image interpretation. Powered by advanced machine learning algorithms, the use of computer vision in endoscopy has the potential to result in better prediction and treatment outcomes for patients with gastroenterology disorders and cancer. Large libraries of endoscopic images, "EndoNet," will be important to facilitate development and application of AI systems. The regulatory environment for implementation of AI systems is evolving, but common outcomes such as colon polyp detection have been highlighted as potential clinical trial endpoints. Other threshold outcomes will be important, as well as clarity on iterative improvement of clinical systems. CONCLUSIONS: Gastroenterology is a prime candidate for early adoption of AI. AI is rapidly moving from an experimental phase to a clinical implementation phase in gastroenterology. It is anticipated that the implementation of AI in gastroenterology over the next decade will have a significant and positive impact on patient care and clinical workflows. Ongoing collaboration among gastroenterologists, industry experts, and regulatory agencies will be important to ensure that progress is rapid and clinically meaningful. However, several constraints and areas will benefit from further exploration, including potential clinical applications, implementation, structure and governance, role of gastroenterologists, and potential impact of AI in gastroenterology.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Parasa S, Wallace M, Bagci U, et al. Proceedings from the First Global Artificial Intelligence in Gastroenterology and Endoscopy Summit. Gastrointest Endosc. 2020. PMID: 32343978. doi:10.1016/j.gie.2020.04.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。